HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma

He,Zebao; Zhu,Jiansheng; Mo,Jinggang; Zhao,Haihong; Chen,Qiuyue

doi:10.3892/mmr.2020.11074

HBV DNA integrates into upregulated ZBTB20 in patients with hepatocellular carcinoma

Authors:
- Zebao He
- Jiansheng Zhu
- Jinggang Mo
- Haihong Zhao
- Qiuyue Chen
View Affiliations

Affiliations: Department of Neurology, Taizhou Enze Medical Center Enze Hospital, Taizhou, Zhejiang 318000, P.R. China, Department of Neurology, Taizhou Central Hospital, Taizhou University Hospital, Taizhou, Zhejiang 318000, P.R. China
Published online on: April 16, 2020 https://doi.org/10.3892/mmr.2020.11074
Pages: 380-386
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatitis B virus (HBV) affects the malignant phenotype of hepatocellular carcinoma (HCC). The aim of the present study was to investigate the integration sites of HBV DNA and the expression of the zinc finger protein, zinc finger and BTB domain containing 20 (ZBTB20) in patients with hepatocellular carcinoma. Integration of the HBV gene was detected using a high‑throughput sequencing technique based on the HBV‑Alu‑PCR method. The expression of ZBTB20 was detected by western blotting. HBVX integration sites were detected in ~70% of the HCC tissue samples. HBV‑integrated subgene X detection suggested that 67% of the integrated specimens were inserted into the host X gene in a forward direction, 57% in a reverse direction, 24% in both forward and reverse directions, and 38% had two HBV integration sites. A total of 3,320 HBV integration sites were identified, including 1,397 in HCC tissues, 1,205 in paracancerous tissues and 718 in normal liver tissues. HBV integration fragments displayed enrichment in the 200‑800 bp region. Additionally, the results suggested that HBV was highly integrated into transmembrane phosphatase with tensin homology, long intergenic non‑protein coding RNA (LINC)00618, LOC101929241, ACTR3 pseudogene 5, LINC00999, LOC101928775, deleted in oesophageal cancer 1, LINC00824, EBF transcription factor 2 and ZBTB20 in tumour tissues. Furthermore, the expression of ZBTB20 was upregulated in HCC tissues compared with normal control liver tissues, and was associated with HBV integration frequency. The present study suggested that HBV DNA integrated into upregulated ZBTB20 in patients with hepatocellular carcinoma, which might promote the occurrence and development of HCC. Furthermore, the results of the present study may provide a theoretical basis for the diagnosis and treatment of HCC.

View Figures

View References

1	Singal AG, Li X, Tiro J, Kandunoori P, Adams-Huet B, Nehra MS and Yopp A: Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med. 128:90.e91–90.e97. 2015. View Article : Google Scholar
2	Zeng Y: Advances in mechanism and treatment strategy of cancer. Cell Mol Biol. 64:1–3. 2018. View Article : Google Scholar : PubMed/NCBI
3	Younossi ZM, Stepanova M, Saab S, Ahmed A, Lam B, Srishord M, Venkatesan C, Wai H and Henry L: The impact of viral hepatitis related hepatocellular carcinoma to post transplant outcomes. J Viral Hepat. 23:53–61. 2016. View Article : Google Scholar : PubMed/NCBI
4	Chisari FV and Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 13:29–60. 1995. View Article : Google Scholar : PubMed/NCBI
5	Wang M, Xi D and Ning Q: Virus-induced hepatocellular carcinoma with special emphasis on HBV. Hepatol Int. 11:171–180. 2017. View Article : Google Scholar : PubMed/NCBI
6	Zeng Y, Yao X, Liu X, He X, Li L, Liu X, Yan Z, Wu J and Fu BM: Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis. J Extracell Vesicles. 8:16298652019. View Article : Google Scholar : PubMed/NCBI
7	Lupberger J and Hildt E: Hepatitis B virus-induced oncogenesis. World J Gastroenterol. 13:74 812007. View Article : Google Scholar : PubMed/NCBI
8	Hino O, Ohtake K and Rogler CE: Features of two hepatitis B virus (HBV) DNA integrations suggest mechanisms of HBV integration. J Virol. 63:2638–2643. 1989. View Article : Google Scholar : PubMed/NCBI
9	Maddrey WC: Hepatitis B: an important public health issue. J Med Virol. 61:362–366. 2000. View Article : Google Scholar : PubMed/NCBI
10	Shlomai A, de Jong YP and Rice CM: Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol. 26:78–88. 2014. View Article : Google Scholar : PubMed/NCBI
11	Dandri M and Locarnini S: New insight in the pathobiology of hepatitis B virus infection. Gut. 61 (Suppl 1):i6–i17. 2012. View Article : Google Scholar : PubMed/NCBI
12	Minami M: Integration of hepatitis B virus genome into the host gene: Its significance to hepatocarcinogenesis. Nihon Rinsho. 73 (Suppl 9):409–413. 2015.(In Japanese). PubMed/NCBI
13	Jiang S, Yang Z, Li W, Li X, Wang Y, Zhang J, Xu C, Chen PJ, Hou J, McCrae MA, et al: Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PLoS One. 7:e403632012. View Article : Google Scholar : PubMed/NCBI
14	Edman JC, Gray P, Valenzuela P, Rall LB and Rutter WJ: Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature. 286:535–538. 1980. View Article : Google Scholar : PubMed/NCBI
15	Tu T, Budzinska MA, Shackel NA and Urban S: HBV DNA Integration: Molecular Mechanisms and Clinical Implications. Viruses. 9:92017. View Article : Google Scholar
16	Yang L, Ye S, Zhao X, Ji L, Zhang Y, Zhou P, Sun J, Guan Y, Han Y, Ni C, et al: Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer. 9:3225–3235. 2018. View Article : Google Scholar : PubMed/NCBI
17	Liu S, Koh SS and Lee CG: Hepatitis B Virus X Protein and Hepatocarcinogenesis. Int J Mol Sci. 17:9402016. View Article : Google Scholar
18	Sung WKZH, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, et al: Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 44:765–769. 2012. View Article : Google Scholar : PubMed/NCBI
19	Kan H, Huang Y, Li X, Liu D, Chen J and Shu M: Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Oncotarget. 7:14336–14349. 2016. View Article : Google Scholar : PubMed/NCBI
20	Yao M, Yao DF, Bian YZ, Wu W, Yan XD, Yu DD, Qiu LW, Yang JL, Zhang HJ, Sai WL, et al: Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 12:171–179. 2013. View Article : Google Scholar : PubMed/NCBI
21	Zhang H, Shi JH, Jiang H, Wang K, Lu JY, Jiang X, Ma X, Chen YX, Ren AJ, Zheng J, et al: ZBTB20 regulates EGFR expression and hepatocyte proliferation in mouse liver regeneration. Cell Death Dis. 9:4622018. View Article : Google Scholar : PubMed/NCBI
22	Xie Z, Zhang H, Tsai W, Zhang Y, Du Y, Zhong J, Szpirer C, Zhu M, Cao X, Barton MC, et al: Zinc finger protein ZBTB20 is a key repressor of alpha fetoprotein gene transcription in liver. Proc Natl Acad Sci U S A. 105:10859–10864. 2008. View Article : Google Scholar : PubMed/NCBI
23	World Health Organization (WHO), . Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. WHO. (Geneva). 2015.
24	Masaki H, Takashi A, Naoto T, Kuwana Y, Shigemoto Y, Miyazaki S, Suzuki Y and Sugawara H: Genome Information Broker for Viruses (GIB-V): database for comparative analysis of virus genomes. Nucleic Acids Res. 35((Database issue)): D339–D342. 2007.PubMed/NCBI
25	Zucman-Rossi J and Laurent-Puig P: Genetic diversity of hepatocellular carcinomas and its potential impact on targeted therapies. Pharmacogenomics. 8:997–1003. 2007. View Article : Google Scholar : PubMed/NCBI
26	Guerrero RB and Roberts LR: The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J Hepatol. 42:760–777. 2005. View Article : Google Scholar : PubMed/NCBI
27	Murakami Y, Saigo K, Takashima H, Minami M, Okanoue T, Bréchot C and Paterlini-Bréchot P: Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut. 54:1162–1168. 2005. View Article : Google Scholar : PubMed/NCBI
28	Zhang W, Mi J, Li N, Sui L, Wan T, Zhang J, Chen T and Cao X: Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6. Biochem Biophys Res Commun. 282:1067–1073. 2001. View Article : Google Scholar : PubMed/NCBI
29	Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, Cao D, Zhang WP, Hu HP and Wang HY: Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. BMC Cancer. 11:2712011. View Article : Google Scholar : PubMed/NCBI
30	Nagao M, Ogata T, Sawada Y and Gotoh Y: Zbtb20 promotes astrocytogenesis during neocortical development. Nat Commun. 7:111022016. View Article : Google Scholar : PubMed/NCBI
31	Chevrier S and Corcoran LM: BTB-ZF transcription factors, a growing family of regulators of early and late B-cell development. mmunol Cell Biol. 92:481–488. 2014. View Article : Google Scholar
32	Maeda T: Regulation of hematopoietic development by ZBTB transcription factors. Int J Hematol. 104:310–323. 2016. View Article : Google Scholar : PubMed/NCBI
33	Cao D, Ma X, Cai J, Luan J, Liu AJ, Yang R, Cao Y, Zhu X, Zhang H, Chen YX, et al: ZBTB20 is required for anterior pituitary development and lactotrope specification. Nat Commun. 7:111212016. View Article : Google Scholar : PubMed/NCBI